Table 3. Most commonly reported treatment-related adverse events in intent-to-treat population in study of treatments for West Nile virus central nervous system disease, by treatment arm*.
| Adverse event | Omr-IgG-am, n = 37 | Polygam, n = 12 | Normal saline, n = 13 | Total, n = 62 |
|---|---|---|---|---|
| Hypertension | 7 | 0 | 2 | 9 |
| Dosing error | 6 | 0 | 2 | 8 |
| Elevated transaminases | 3 | 1 | 0 | 4 |
| Fever, chills | 3 | 1 | 0 | 4 |
| Shortness of breath | 0 | 3 | 0 | 3 |
| Rash, pruritus | 2 | 0 | 0 | 2 |
| Chest pain | 2 | 0 | 0 | 2 |
| Other |
6 |
2 |
1 |
9 |
| Total | 29 | 7 | 5 | 41 |
*Values are no. patients.